Reports Q3 revenue $1.71B, consensus $1.73B. “Our team delivered another quarter of solid financial results, including outperformance in bioprocessing and a return to growth in our laboratory solutions segment. Our disciplined approach to working capital drove another quarter of best-in-class free cash flow conversion and we are raising our free cash flow guidance for the year,” said Michael Stubblefield, president and CEO.
Education
About Us
Working with TipRanks
Follow Us
1